aCME | nCME | P value | Adjusted P value1 | |
---|---|---|---|---|
Demographic data | ||||
Number of eyes | 25 (25%) | 74 (75%) | ||
Follow-up (months) | 21.4 ± 12.1 | 20.4 ± 10.8 | 0.87 | |
Sex, Female | 8 (32%) | 38 (34%) | 0.09 | |
Age (years) | 64.1 ± 11.6 | 56.7 ± 18.0 | 0.09 | |
Clinical data | ||||
Right eye | 11 (44%) | 40 (54%) | 0.38 | |
Glaucoma | 4 (16%) | 6 (8%) | 0.26 | |
Lens status | < 0.001 | 0.008 | ||
Phakic | 1 (4%) | 44 (60%) | ||
Pseudophakic | 14 (56%) | 28 (38%) | ||
Aphakic | 10 (40%) | 2 (3%) | ||
Macula offa | 20/24 (83%) | 31/70 (44%) | 0.001 | 0.06 |
PVR Stage Ca | 15/24 (63%) | 5/74 (7%) | < 0.001 | 0.09 |
Final VA (LogMAR) | 0.85 ± 0.80 | 0.20 ± 0.30 | < 0.001 | 0.012b |
ERM | 18 (72%) | 28 (38%) | 0.005 | |
Surgical details | ||||
Number of surgeries | 3.5 ± 1.8 | 1.4 ± 0.9 | < 0.001 | |
Multiple PPV | 21 (84%) | 17 (23%) | < 0.001 | –c |
Referred after surgery elsewhere | 12 (48%) | 5 (7%) | < 0.001 | 0.31 |
Number of surgery outside | 1 ± 1.3 | 0.095 ± 0.4 | < 0.001 | |
Type of surgery | < 0.001 | 0.21 | ||
SB | 1 (4%) | 25 (34%) | ||
PPV | 7 (28%) | 28 (38%) | ||
PPV + SB | 17 (68%) | 21 (28%) | ||
Tamponade agent | < 0.001 | 0.10 | ||
None/Air | 1 (4%) | 24 (32%) | ||
Gas (SF6 or C3F8) | 8 (32%) | 46 (62%) | ||
Silicone oil | 16 (64%) | 4 (5%) | ||
Cryotherapya | 4/24 (17%) | 30/73 (41%) | 0.047 | 0.036 |
Retinectomy | 9 (36%) | 4 (5%) | < 0.001 | 0.009 |
PFCLa | 18/23 (78%) | 35/47 (75%) | 0.73 | 0.38 |